207 
‘‘(II) intended to respond to high- 
priority or emergent campaign needs 
that cannot timely be obtained at no 
cost (not including production costs 
and talent reuse payments), provided 
that any such advertising material is 
reviewed by the Partnership for a 
Drug-Free America; 
‘‘(III) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot be obtained at no cost (not 
including production costs and talent 
reuse payments), provided that any 
such advertising material is reviewed 
by the Partnership for a Drug-Free 
America; or 
‘‘(IV) any other advertisements 
that the Director determines that the 
Partnership for a Drug-Free America 
is unable to provide. 
‘‘(C) MEDIA
BUYING
CONTRACTOR.—The 
Director shall enter into a contract with a media 
buying contractor to plan and purchase adver-
tising time and space for the national media 
campaign. The media buying contractor shall 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00207
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
208 
not provide any other service or material, or 
conduct any other function or activity which the 
Director determines should be provided by the 
Partnership for a Drug-Free America. 
‘‘(e) PROHIBITIONS.—None of the amounts made 
available under subsection (b) may be obligated or expended 
for any of the following: 
‘‘(1) To supplant current antidrug community- 
based coalitions. 
‘‘(2) To supplant pro bono public service time 
donated by national and local broadcasting networks 
for other public service campaigns. 
‘‘(3) For partisan political purposes, or express 
advocacy in support of or to defeat any clearly identi-
fied candidate, clearly identified ballot initiative, or 
clearly identified legislative or regulatory proposal. 
‘‘(4) To fund advertising that features any elect-
ed officials, persons seeking elected office, cabinet level 
officials, or other Federal officials employed pursuant 
to section 213 of Schedule C of title 5, Code of Federal 
Regulations. 
‘‘(5) To fund advertising that does not contain 
a primary message intended to reduce or prevent il-
licit drug use. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00208
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
209 
‘‘(6) To fund advertising containing a primary 
message intended to promote support for the media 
campaign or private sector contributions to the media 
campaign. 
‘‘(f) MATCHING REQUIREMENT.— 
‘‘(1) IN
GENERAL.—Amounts made available 
under subsection (b) for media time and space shall 
be matched by an equal amount of non-Federal funds 
for the national media campaign, or be matched with 
in-kind contributions of the same value. 
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse pre-
vention consistent with the specific purposes of the 
national media campaign, except that in any fiscal 
year in which less than $125,000,000 is appropriated 
to the national media campaign, the Director shall 
ensure that at least 85 percent of no-cost match ad-
vertising directly relates to substance abuse preven-
tion consistent with the specific purposes of the na-
tional media campaign. 
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY
RELATED.—The Director shall ensure that 
no-cost match advertising that does not directly relate 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00209
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
210 
to substance abuse prevention consistent with the pur-
poses of the national media campaign includes a clear 
antidrug message. Such message is not required to be 
the primary message of the match advertising. 
‘‘(g) 
FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed— 
‘‘(1) audits and reviews of costs of the national 
media campaign pursuant to section 304C of the Fed-
eral Property and Administrative Services Act of 
1949 (41 U.S.C. 254d); and 
‘‘(2) an audit to determine whether the costs of 
the national media campaign are allowable under sec-
tion 306 of such Act (41 U.S.C. 256). 
‘‘(h) REPORT TO CONGRESS.—The Director shall sub-
mit on an annual basis a report to Congress that de-
scribes— 
‘‘(1) the strategy of the national media cam-
paign and whether specific objectives of the media 
campaign were accomplished; 
‘‘(2) steps taken to ensure that the national 
media campaign operates in an effective and efficient 
manner consistent with the overall strategy and focus 
of the national media campaign; 
‘‘(3) plans to purchase advertising time and 
space; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00210
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
211 
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the 
potential for waste, fraud, and abuse; and 
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the national media campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 
shall, to the maximum extent feasible, use amounts made 
available under this section for media that focuses on, or 
includes specific information on, prevention or treatment 
resources for consumers within specific local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.— 
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing: 
‘‘(A) 60 percent of adolescent admissions for 
drug treatment are based on marijuana use. 
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past, 
rising from under 1 percent of THC in the mid- 
1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00211
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
212 
in life may be up to five times more likely to use 
hard drugs. 
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
educational achievement resulting from mari-
juana use. 
‘‘(E) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
brain development resulting from marijuana use. 
‘‘(F) An estimated 9,000,000 Americans a 
year drive while under the influence of illegal 
drugs, including marijuana. 
‘‘(G) Marijuana smoke contains 50 to 70 
percent more of certain cancer causing chemicals 
than tobacco smoke. 
‘‘(H) Teens who use marijuana are up to 
four times more likely to have a teen pregnancy 
than teens who have not. 
‘‘(I) Federal law enforcement agencies have 
identified clear links suggesting that trade in hy-
droponic marijuana facilitates trade by criminal 
organizations in hard drugs, including heroin. 
‘‘(J) Federal law enforcement agencies have 
identified possible links between trade in can-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00212
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
213 
nabis products and financing for terrorist orga-
nizations. 
‘‘(2) EMPHASIS ON PREVENTION OF YOUTH MARI-
JUANA USE.—In conducting advertising and activities 
otherwise authorized under this section, the Director 
may emphasize prevention of youth marijuana use. 
‘‘(k) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to the Office to carry out this 
section, $195,000,000 for each of fiscal years 2007 and 2008 
and $210,000,000 for each of fiscal years 2009 through 
2011.’’. 
(b) REPEAL
OF
SUPERSEDED
PROVISIONS.—The 
Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is repealed. 
SEC. 13. DRUG INTERDICTION. 
(a) IN GENERAL.—Subsections (a) and (b) of section 
711 (21 U.S.C. 1710) are amended to read as follows: 
‘‘(a) UNITED STATES INTERDICTION COORDINATOR.— 
‘‘(1) IN
GENERAL.—The Deputy Director for 
Supply Reduction in the Office shall serve as the 
United States Interdiction Coordinator, and shall 
perform the duties of that position described in para-
graph (2) and such other duties as may be determined 
by the Director with respect to coordination of efforts 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00213
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
214 
to interdict illicit drugs from entering the United 
States. 
‘‘(2) RESPONSIBILITIES.—The United States 
Interdiction Coordinator shall be responsible to the 
Director for— 
‘‘(A) coordinating the interdiction activities 
of the National Drug Control Program agencies 
to ensure consistency with the National Drug 
Control Strategy; 
‘‘(B) on behalf of the Director, developing 
and issuing, on or before March 1 of each year 
and in accordance with paragraph (3), a Na-
tional Interdiction Command and Control Plan 
to ensure the coordination and consistency de-
scribed in subparagraph (A); 
‘‘(C) assessing the sufficiency of assets com-
mitted to illicit drug interdiction by the relevant 
National Drug Control Program agencies; and 
‘‘(D) advising the Director on the efforts of 
each National Drug Control Program agency to 
implement the National Interdiction Command 
and Control Plan. 
‘‘(3) STAFF.—The Director shall assign such per-
manent staff of the Office as he considers appropriate 
to assist the United States Interdiction Coordinator 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00214
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
215 
to carry out the responsibilities described in para-
graph (2), and may also, at his discretion, request 
that appropriate National Drug Control Program 
agencies detail or assign staff to the Office of Supply 
Reduction for that purpose. 
‘‘(4) NATIONAL
INTERDICTION
COMMAND
AND 
CONTROL PLAN.— 
‘‘(A) PURPOSES.—The National Interdic-
tion Command and Control Plan shall— 
‘‘(i) set forth the Government’s strategy 
for drug interdiction; 
‘‘(ii) state the specific roles and respon-
sibilities of the relevant National Drug Con-
trol Program agencies for implementing 
that strategy; and 
‘‘(iii) identify the specific resources re-
quired to enable the relevant National Drug 
Control Program agencies to implement 
that strategy. 
‘‘(B) CONSULTATION
WITH
OTHER
AGEN-
CIES.—The United States Interdiction Coordi-
nator shall issue the National Interdiction Com-
mand and Control Plan in consultation with the 
other members of the Interdiction Committee de-
scribed in subsection (b). 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00215
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
216 
‘‘(C) LIMITATION.—The National Interdic-
tion Command and Control Plan shall not 
change existing agency authorities or the laws 
governing interagency relationships, but may in-
clude recommendations about changes to such 
authorities or laws. 
‘‘(D) REPORT TO CONGRESS.—On or before 
March 1 of each year, the United States Interdic-
tion Coordinator shall provide a report on behalf 
of the Director to the appropriate congressional 
committees, to the Committee on Armed Services 
and the Committee on Homeland Security of the 
House of Representatives, and to the Committee 
on Homeland Security and Governmental Af-
fairs and the Committee on Armed Services of 
the Senate, which shall include— 
‘‘(i) a copy of that year’s National 
Interdiction Command and Control Plan; 
‘‘(ii) information for the previous 10 
years regarding the number and type of sei-
zures of drugs by each National Drug Con-
trol Program agency conducting drug inter-
diction activities, as well as statistical in-
formation on the geographic areas of such 
seizures; and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00216
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
217 
‘‘(iii) information for the previous 10 
years regarding the number of air and mar-
itime patrol hours undertaken by each Na-
tional Drug Control Program agency con-
ducting drug interdiction activities, as well 
as statistical information on the geographic 
areas in which such patrol hours took place. 
‘‘(E) TREATMENT OF CLASSIFIED OR LAW 
ENFORCEMENT
SENSITIVE
INFORMATION.—Any 
content of the report described in subparagraph 
(D) that involves information classified under 
criteria established by an Executive order, or the 
public disclosure of which, as determined by the 
United States Interdiction Coordinator or the 
head of any relevant National Drug Control Pro-
gram agency, would be detrimental to the law 
enforcement or national security activities of any 
Federal, State, or local agency, shall be presented 
to Congress separately from the rest of the plan. 
‘‘(b) INTERDICTION COMMITTEE.— 
‘‘(1) IN GENERAL.—The Interdiction Committee 
shall meet to— 
‘‘(A) discuss and resolve issues related to the 
coordination, oversight and integration of inter-
national, border, and domestic drug interdiction 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00217
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
218 
efforts in support of the National Drug Control 
Strategy; 
‘‘(B) review the annual National Interdic-
tion Command and Control Plan, and provide 
advice to the Director and the United States 
Interdiction Coordinator concerning that plan; 
and 
‘‘(C) provide such other advice to the Direc-
tor concerning drug interdiction strategy and 
policies as the committee determines is appro-
priate. 
‘‘(2) MEMBERSHIP.—The membership of the 
Interdiction Committee shall consist of— 
‘‘(A) the Commissioner of the bureau of 
Customs and Border Protection at the Depart-
ment of Homeland Security; 
‘‘(B) the Assistant Secretary of the bureau 
of Immigration and Customs Enforcement at the 
Department of Homeland Security; 
‘‘(C) the Commandant of the United States 
Coast Guard; 
‘‘(D) the Director of the Office of Counter-
narcotics Enforcement at the Department of 
Homeland Security; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00218
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
219 
‘‘(E) the Administrator of the Drug En-
forcement Administration; 
‘‘(F) the Assistant Secretary of State for 
International Narcotics and Law Enforcement 
Affairs; 
‘‘(G) the Assistant Secretary of Defense for 
Special Operations and Low Intensity Conflict; 
‘‘(H) the Deputy Director for Supply Re-
duction of the Office of National Drug Control 
Policy, acting in his role as the United States 
Interdiction Coordinator; 
‘‘(I) the director of the Crime and Narcotics 
Center of the Central Intelligence Agency; 
‘‘(J) the Deputy Director for State and 
Local Affairs of the Office of National Drug Con-
trol Policy; 
‘‘(K) the Chief of the National Guard Bu-
reau’s Counterdrug Program; and 
‘‘(L) such additional persons as may be de-
termined by the Director. 
‘‘(3) CHAIRMAN.—The Director shall designate 
one of the members of the Interdiction Committee to 
serve as chairman. 
‘‘(4) MEETINGS.—The members of the Interdic-
tion Committee shall meet, in person and not through 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00219
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
220 
any delegate or representative, at least once per cal-
endar year, prior to March 1. At the call of either the 
Director or the current chairman, the Interdiction 
Committee may hold additional meetings, which shall 
be attended by the members either in person, or 
through such delegates or representatives as they may 
choose. 
‘‘(5) REPORT.—Not later than September 30 of 
each year, the chairman of the Interdiction Com-
mittee shall submit a report to the Director and to the 
appropriate congressional committees describing the 
results of the meetings and any significant findings 
of the Committee during the previous 12 months. Any 
content of such a report that involves information 
classified under criteria established by an Executive 
order, or whose public disclosure, as determined by 
the Director, the chairman, or any member, would be 
detrimental to the law enforcement or national secu-
rity activities of any Federal, State, or local agency, 
shall be presented to Congress separately from the rest 
of the report.’’. 
(b) CONFORMING AMENDMENT TO HOMELAND SECU-
RITY ACT OF 2002.—Section 878 of the Homeland Security 
Act of 2002 (6 U.S.C. 458) is amended— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00220
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
221 
(1) in subsection (c), by striking ‘‘Except as pro-
vided in subsection (d), the’’ and inserting ‘‘The’’; 
and 
(2) by striking subsection (d) and redesignating 
subsections (e), (f), and (g) as subsections (d), (e), and 
(f), respectively. 
SEC. 14. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO SHUT DOWN IL-
LICIT DRUG MARKET HOT-SPOTS BY DETER-
RING DRUG DEALERS OR ALTERING THE DY-
NAMIC OF DRUG SALES. 
Sections 713 and 714 (21 U.S.C. 1711) are redesig-
nated as sections 715 and 716, respectively, and after sec-
tion 712 (21 U.S.C. 1710) insert the following new section: 
‘‘SEC. 713 AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO SHUT DOWN IL-
LICIT DRUG MARKET HOT-SPOTS BY DETER-
RING DRUG DEALERS OR ALTERING THE DY-
NAMIC OF DRUG SALES. 
‘‘(a) AWARDS REQUIRED.—The Director shall make 
competitive awards for demonstration programs by eligible 
partnerships for the purpose of shutting down local illicit 
drug market hot-spots and reducing drug-related crime 
through evidence-based, strategic problem-solving interven-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00221
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
222 
tions that deter drug dealers or alter the dynamic of drug 
sales. 
‘‘(b) USE OF AWARD AMOUNTS.—Award amounts re-
ceived under this section shall be used— 
‘‘(1) to support the efforts of the agencies, organi-
zations, and researchers included in the eligible part-
nership; 
‘‘(2) to develop and field a directed and credible 
deterrent threat; and 
‘‘(3) to strengthen rehabilitation efforts through 
such means as job training, drug treatment, or other 
services. 
‘‘(c) ELIGIBLE PARTNERSHIP DEFINED.—In this sec-
tion, the term ‘eligible partnership’ means a working group 
whose application to the Director— 
‘‘(1) identifies the roles played, and certifies the 
involvement of, three or more agencies or organiza-
tions, which may include— 
‘‘(A) State or local agencies (such as those 
carrying out police, probation, prosecution, 
courts, corrections, parole, or treatment func-
tions); 
‘‘(B) Federal agencies (such as the Drug 
Enforcement Agency, the Bureau of Alcohol, To-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00222
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
223 
bacco, Firearms, and Explosives, and United 
States Attorney offices); and 
‘‘(C) community-based organizations; 
‘‘(2) includes a qualified researcher; 
‘‘(3) includes a plan for identifying the impact 
players in, and assessing the nature and dynamic of, 
the local drug market and its related crime through 
information gathering and analysis; 
‘‘(4) includes a plan for developing an evidence- 
based strategic intervention aimed at quickly and 
sustainably eradicating the local drug market by de-
terring drug dealers or altering the dynamic of drug 
sales; and 
‘‘(5) includes a plan that describes the method-
ology and outcome measures proposed for evaluating 
the impact of that strategic intervention on drug 
sales, neighborhood disorder, and crime. 
‘‘(d) REPORTS TO CONGRESS.— 
‘‘(1) INTERIM REPORT.—Not later than June 1, 
2009, the Director shall submit to Congress a report 
that identifies the best practices in drug market 
eradication, including the best practices identified 
through the activities funded under this section. 
‘‘(2) FINAL REPORT.—Not later than June 1, 
2010, the Director shall submit to Congress a report 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00223
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
224 
on the demonstration programs funded under this sec-
tion, including on the matters specified in paragraph 
(1). 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$10,000,000 for each of fiscal years 2007 through 2009.’’. 
SEC. 15. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO COERCE ABSTI-
NENCE 
IN 
CHRONIC 
HARD-DRUG 
USERS 
UNDER COMMUNITY SUPERVISION THROUGH 
THE USE OF DRUG TESTING AND SANCTIONS. 
After section 713, as inserted by section 14 of this Act, 
insert the following new section: 
‘‘SEC. 714. AWARDS FOR DEMONSTRATION PROGRAMS BY 
LOCAL PARTNERSHIPS TO COERCE ABSTI-
NENCE 
IN 
CHRONIC 
HARD-DRUG 
USERS 
UNDER COMMUNITY SUPERVISION THROUGH 
THE USE OF DRUG TESTING AND SANCTIONS. 
‘‘(a) AWARDS REQUIRED.—The Director shall make 
competitive awards to fund demonstration programs by eli-
gible partnerships for the purpose of reducing the use of 
illicit drugs by chronic hard-drug users living in the com-
munity while under the supervision of the criminal justice 
system. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00224
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
225 
‘‘(b) USE OF AWARD AMOUNTS.—Award amounts re-
ceived under this section shall be used— 
‘‘(1) to support the efforts of the agencies, organi-
zations, and researchers included in the eligible part-
nership; 
‘‘(2) to develop and field a drug testing and 
graduated sanctions program for chronic hard-drug 
users living in the community under criminal justice 
supervision; and 
‘‘(3) to assist individuals described in subsection 
(a) by strengthening rehabilitation efforts through 
such means as job training, drug treatment, or other 
services. 
‘‘(c) ELIGIBLE PARTNERSHIP DEFINED.—In this sec-
tion, the term ‘eligible partnership’ means a working group 
whose application to the Director— 
‘‘(1) identifies the roles played, and certifies the 
involvement of, two or more agencies or organiza-
tions, which may include— 
‘‘(A) State or local agencies (such as those 
carrying out police, probation, prosecution, 
courts, corrections, parole, or treatment func-
tions); 
‘‘(B) Federal agencies (such as the Drug 
Enforcement Agency, the Bureau of Alcohol, To-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00225
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
226 
bacco, Firearms, and Explosives, and United 
States Attorney offices); and 
‘‘(C) community-based organizations; 
‘‘(2) includes a qualified researcher; 
‘‘(3) includes a plan for using judicial or other 
criminal justice authority to administer drug tests to 
individuals described in subsection (a) at least twice 
a week, and to swiftly and certainly impose a known 
set of graduated sanctions for non-compliance with 
community-release provisions relating to drug absti-
nence (whether imposed as a pre-trial, probation, or 
parole condition or otherwise); 
‘‘(4) includes a strategy for responding to a 
range of substance use and abuse problems and a 
range of criminal histories; 
‘‘(5) includes a plan for integrating data infra-
structure among the agencies and organizations in-
cluded in the eligible partnership to enable seamless, 
real-time tracking of individuals described in sub-
section (a); 
‘‘(6) includes a plan to monitor and measure the 
progress toward reducing the percentage of the popu-
lation of individuals described in subsection (a) who, 
upon being summoned for a drug test, either fail to 
show up or who test positive for drugs. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00226
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
227 
‘‘(d) REPORTS TO CONGRESS.— 
‘‘(1) INTERIM REPORT.—Not later than June 1, 
2009, the Director shall submit to Congress a report 
that identifies the best practices in reducing the use 
of illicit drugs by chronic hard-drug users, including 
the best practices identified through the activities 
funded under this section. 
‘‘(2) FINAL REPORT.—Not later than June 1, 
2010, the Director shall submit to Congress a report 
on the demonstration programs funded under this sec-
tion, including on the matters specified in paragraph 
(1). 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$10,000,000 for each of fiscal years 2007 through 2009.’’. 
SEC. 16. AUTHORIZATION OF APPROPRIATIONS. 
Section 716 (21 U.S.C. 1711), as redesignated by sec-
tion 14 of this Act, is amended— 
(1) by striking ‘‘title,’’ and inserting ‘‘title, ex-
cept activities for which amounts are otherwise spe-
cifically authorized by this title,’’; and 
(2) by striking ‘‘1999 through 2003’’ and insert-
ing ‘‘2007 through 2011’’. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00227
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
228 
SEC. 17. TECHNICAL AMENDMENTS AND REPEAL. 
(a) AMENDMENT TO PUBLIC HEALTH SERVICE ACT TO 
REPLACE OBSOLETE REFERENCES.—Section 464P(c) of 
the Public Health Service Act (42 U.S.C. 285o–4(c)) is 
amended— 
(1) in paragraph (1), by striking ‘‘under section 
1002 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 
1501)’’ and inserting ‘‘under section 703 of the Office 
of National Drug Control Policy Reauthorization Act 
of 1998 (21 U.S.C. 1702)’’; and 
(2) in paragraph (2), by striking ‘‘under section 
1005 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 
1504)’’ and inserting ‘‘under section 706 of the Office 
of National Drug Control Policy Reauthorization Act 
of 1998 (21 U.S.C. 1705)’’. 
(b) REPEAL OF SPECIAL FORFEITURE FUND.—Section 
6073 of the Asset Forfeiture Amendments Act of 1988 (21 
U.S.C. 1509) is repealed. 
SEC. 18. REQUIREMENT FOR DISCLOSURE OF FEDERAL 
SPONSORSHIP 
OF 
ALL 
FEDERAL 
ADVER-
TISING OR OTHER COMMUNICATION MATE-
RIALS. 
Section 712 is amended to read as follows: 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00228
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
229 
‘‘SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL 
SPONSORSHIP 
OF 
ALL 
FEDERAL 
ADVER-
TISING OR OTHER COMMUNICATION MATE-
RIALS. 
‘‘(a) REQUIREMENT.—Each advertisement or other 
communication paid for by the Office, either directly or 
through a contract awarded by the Office, shall include a 
prominent notice informing the target audience that the ad-
vertisement or other communication is paid for by the Of-
fice. 
‘‘(b) ADVERTISEMENT OR OTHER COMMUNICATION.— 
In this section, the term ‘advertisement or other commu-
nication’ includes— 
‘‘(1) an advertisement disseminated in any form, 
including print or by any electronic means; and 
‘‘(2) a communication by an individual in any 
form, including speech, print, or by any electronic 
means.’’. 
SEC. 19. POLICY RELATING TO SYRINGE EXCHANGE PRO-
GRAMS. 
Section 703(a) (21 U.S.C. 1702(a)) is amended by 
adding at the end the following: 
‘‘When developing the national drug control policy, any pol-
icy of the Director relating to syringe exchange programs 
for intravenous drug users shall be based on the best avail-
able medical and scientific evidence regarding their effec-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00229
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
230 
tiveness in promoting individual health and preventing the 
spread of infectious disease, and their impact on drug ad-
diction and use. In making any policy relating to syringe 
exchange programs, the Director shall consult with the Na-
tional Institutes of Health and the National Academy of 
Sciences.’’. 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00230
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00231
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
Union Calendar No. 209 
109TH CONGRESS 
2D SESSION 
H. R. 2829 
[Report No. 109–315, Parts I, II, and III] 
A BILL 
To reauthorize the Office of National Drug Control 
Policy Act. 
MARCH 3, 2006 
Reported from the Committee on Energy and Commerce 
with an amendment 
MARCH 3, 2006 
Reported from the Committee on the Judiciary with an 
amendment 
MARCH 3, 2006 
The Permanent Select Committee on Intelligence and the 
Committee on Education and the Workforce dis-
charged; committed to the Committee of the Whole 
House on the State of the Union and ordered to be 
printed 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00232
Fmt 6651
Sfmt 6651
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS